: iStockAnalyst.com Symbols Feed

Options Intellignece Report : Options Activity for XRT, CVS, STT, PFE, FSYS & AEO

Thu, 05 Nov 2009 19:12:19 GMT

Today's tickers: XRT, CVS, STT, PFE, CVS, FSYS & AEO[More...]

Healthcare M&A Activitiy: Three Healthcare Small Caps Primed For Takeovers

Thu, 22 Oct 2009 16:22:43 GMT

With the healthcare debate still raging in Washington, this should shock you… Healthcare mergers and acquisition (M&A) activity is at an all-time high.[More...]

Wall Street Slumps On Wells Fargo Downgrade, JP Morgan (NYSE: JPM) Sinks

Wed, 21 Oct 2009 23:32:38 GMT

US stocks finished with losses after a bearish analyst note by Rochdale Securities' banking analyst Dick Bove rattled investors.[More...]

Wall Street Declines On Disappointing Housing Data, Boeing Co (NYSE: BA) Tumbles

Tue, 20 Oct 2009 22:55:00 GMT

US stocks finished down on Tuesday as weaker-than-expected housing data outweighed strong corporate quarterly earnings.[More...]

IB Breakfast of Champions: Morning Movers

Tue, 20 Oct 2009 16:12:02 GMT

Today's tickers: AAPL, PFE, CAT[More...]

Pfizer (PFE) Reports; Should I Sell My Shares?

Tue, 20 Oct 2009 15:45:27 GMT

Now that I own some Pfizer stock (due to the acquisition of Wyeth), I feel obligated to at least post on Pfizer's earnings. (marketwatch) -The world's largest drug maker posted net income of $2.88 billion, or 43 cents a share, compared with $2.28 billion, or 34 cents a share, for the same quarter[More...]

US Stock Futures Advance On Upbeat Earnings, Apple (NASDAQ: AAPL) Eyed

Tue, 20 Oct 2009 12:46:23 GMT

US stock futures climbed on Tuesday as strong earnings from Apple and Texas Instruments buoyed investor optimism about the corporate performance.[More...]

Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts

Tue, 20 Oct 2009 02:19:35 GMT

At the beginning of the month, Celldex Therapeutics (NASDAQ: CLDX) announced the successful completion of its acquisition of CuraGen (formerly CRGN), which strengthens the balance sheet (approx. $85 million in cash / equivalents) while expanding the pipeline and increasing the expected news flow of clinical data catalysts for the combined entity[More...]

Most Active Stock Options October 19, 2009

Mon, 19 Oct 2009 23:31:25 GMT

As of today the top ten most active option contracts traded were:[More...]

Pfizer Inc (NYSE:PFE): Third Quarter Earnings Preview 2009

Mon, 19 Oct 2009 20:55:00 GMT

Pfizer Inc (PFE), the world's largest drug company, is scheduled to report their third quarter results on Tuesday, October 20, 2009.[More...]

Business Highlights

Mon, 02 Nov 2009 22:47:00 GMT

3 strong economic reports lift recovery hopes
WASHINGTON (AP) - Hopes for the fledgling economic recovery got a boost Monday from better-than-expected news on manufacturing, construction and contracts to buy homes.
Construction spending rose a bigger-than-expected a 0.8 percent in September, while the National Association of Realtors said the volume of signed contracts to buy previously occupied homes rose 6.1 percent in September to a reading of 110.1.

: iStockAnalyst.com Symbols Feed

Options Intellignece Report : Options Activity for XRT, CVS, STT, PFE, FSYS & AEO

Healthcare M&A Activitiy: Three Healthcare Small Caps Primed For Takeovers

Wall Street Slumps On Wells Fargo Downgrade, JP Morgan (NYSE: JPM) Sinks

Wall Street Declines On Disappointing Housing Data, Boeing Co (NYSE: BA) Tumbles

IB Breakfast of Champions: Morning Movers

Pfizer (PFE) Reports; Should I Sell My Shares?

US Stock Futures Advance On Upbeat Earnings, Apple (NASDAQ: AAPL) Eyed

Celldex Therapeutics (NASDAQ: CLDX): Plenty of Cash and Pending Clinical Catalysts

Most Active Stock Options October 19, 2009

Pfizer Inc (NYSE:PFE): Third Quarter Earnings Preview 2009

Business Highlights

Lazard: Wasserstein stock leads to $86.5M charge

Lazard: Wasserstein options lead to $86.5M charge

Unilab, Pfizer Figure in 'Drug War'

Pfizer Sues Unilab Over Lipitor Drug

Bristol-Myers posts higher 3Q sales, lower profit

Eli Lilly CEO banking on new drug pipeline

Leading indicators signal growth, but jobs scarce

Pfizer Q3 Net Income Up 26%

Earnings Preview: Bristol-Myers 3Q earnings report

Celldex Therapeutics Reports Third Quarter and Nine Month 2009 Financial Results

PicksThatMove.Com Announces Investment Opinion on TPS, ML, KOG, GAP and PFE

MichBio Expo &Amp; Conference Exhibitors Profiled

Ligand to Acquire Metabasis for Cash and Contingent Value Rights

Mission Bay Capital Announces First Venture Fund

ArthroCare Names David Fitzgerald President and CEO

Cutting Edge Information Investigates Pfizer-Wyeth Merger, Studies Current M&Amp;A Drivers

Kansas City Business Journalist Announces American Innovation Tour

Pfizer Reports Third-Quarter 2009 Results

Health Discovery Corporation Announces Additional Issued Patents and Notices of Allowance to Its Intellectual Property Portfolio

Form 4 Redmond Cavan M. For: Oct 30 (10K)

Form 4 Dolsten Mikael For: Oct 30 (10K)

Form 4 SUSMAN SALLY For: Oct 30 (10K)

Form 4 RINGO WILLIAM R For: Oct 30 (10K)

Form 4 PFIZER INC For: Oct 30 Filed by: RICCIARDI NATALE S (10K)

Form 4 READ IAN C For: Oct 30 (10K)

Form 4 MCLEOD MARY S For: Oct 30 (10K)

Form 4 MACKAY MARTIN For: Oct 30 (10K)

Form 4 Lewis-Hall Freda C For: Oct 30 (10K)

Form 4 DAMELIO FRANK A For: Oct 30 (10K)